It remains unclear whether dietary salt intake over years (not just at baseline) influences hard outcomes. We have previously demonstrated an increased risk of mortality in patients with type 2 diabetes (T2D) and low baseline 24-h urinary sodium excretion (24hU Na ) (1). Based on the same cohort of patients, the aim of the current study was to examine the relationship among serial measurements of 24hU Na , estimated glomerular filtration rate (eGFR), and allcause mortality, adjusting for covariates associated with 24hU Na and eGFR.
It remains unclear whether dietary salt intake over years (not just at baseline) influences hard outcomes. We have previously demonstrated an increased risk of mortality in patients with type 2 diabetes (T2D) and low baseline 24-h urinary sodium excretion (24hU Na ) (1) . Based on the same cohort of patients, the aim of the current study was to examine the relationship among serial measurements of 24hU Na , estimated glomerular filtration rate (eGFR), and allcause mortality, adjusting for covariates associated with 24hU Na and eGFR.
This was a prospective cohort study of patients with T2D attending a single tertiary hospital diabetes clinic, initiated in mid-2000 with follow-up completed in 2010 (1) . Serial 24hU Na (mmol/24 h) and eGFR (mL/min/1.73 m 2 ) measurements were performed at regular intervals. The impact of 24hU Na and eGFR over time on all-cause mortality was determined by a joint model of longitudinal (linear-mixed model) and time-to-event (Weibull parametric survival model) data.
Follow-up 24hU Na and eGFR data from 588 patients were used in the current analysis. There were 152 deaths (26%) after a median follow-up of 9 years. Significant predictors of eGFR in the linear-mixed model were baseline eGFR and BMI, age, sex, follow-up time (years), and 24hU Na and albumin excretion rate over time. Survival model predictors were sex, 24hU Na , and eGFR over time; baseline eGFR; diastolic blood pressure; presence of congestive heart failure and/or atrial fibrillation; and duration of diabetes.
The relationship between all-cause mortality and 24hU Na (adjusted for covariates) is demonstrated in Fig. 1 , where an increase in all-cause mortality was evident in those with lower 24hU Na . Predicted survival at 9.5 years ranged from 94% (24hU Na 5 264 mmol/24 h; 90th percentile) to 77.5% (24hU Na 5 96 mmol/24 h; 10th percentile).
Low 24hU Na was associated with increased all-cause mortality, allowing for changes in 24hU Na and eGFR over time, consistent with the original study findings (1).
Limitations are recognized. Observational data presented here are restricted to patients with long-standing T2D and our analysis is hypothesisgenerating rather than identifying a direct causal relationship. Furthermore, observational studies may be subject to confounding.
The strengths are the use of multiple 24hU Na measurements to estimate dietary salt intake over time in each individual and the use of a joint model for statistical analysis (2,3). Joint modeling has not been previously used to predict mortality in cohort studies of dietary salt intake and has the advantage that over time repeated measurements can reduce measurement error and overcome the effect of treatment of covariates (4). Low 24hU Na excretion over time was associated with increased mortality in people with T2D. The study findings are in line with the Institute of Medicine report (5) no longer recommending lowering sodium intake to #65 mmol/24 h in patients with diabetes. These findings call for research on the effects of habitual low salt intake on markers of reninangiotensin-aldosterone system activity, endothelial function, and sympathetic nervous system activity in people with diabetes. Studies, now in progress, should help to resolve the question of whether low dietary salt intake is a pathogenetic factor, as opposed to a marker, for cardiovascular or renal events in diabetes. Australian Institute of Health and Welfare for assistance during data collection for this project. 
